血清分泌型卷曲相关蛋白5、颗粒蛋白前体、生长分化因子15水平对膝骨关节炎进展的预测价值分析OA
Analysis of the predictive value of serum levels of secreted frizzled-related protein 5,progranulin,and growth differentiation factor 15 for the progression of knee osteoarthritis
目的:探讨血清分泌型卷曲相关蛋白 5(secreted frizzled-related protein 5,SFRP5)、颗粒蛋白前体(progranulin,PGRN)、生长分化因子15(growth differentiation factor 15,GDF15)水平对膝骨关节炎(knee osteoarthritis,KOA)进展的预测价值.方法:选取2022 年3 月至2025 年3 月收治的 123 例 KOA 患者及同期招募的 120 例健康志愿者.收集 KOA 患者的性别、年龄、Kellgren-Lawrence(K-L)分级、体质量指数、病程等信息及健康志愿者性别、年龄等信息.于清晨空腹状态下抽取受试者的静脉血,采用ELISA 法检测受试者血清 SFRP5、PGRN、GDF15 水平.将 KOA 患者纳入 KOA 组,将健康志愿者纳入健康对照组,比较 2 组受试者的血清 SFRP5、PGRN、GDF15 水平.将 K-L 分级为Ⅰ级和Ⅱ级的 KOA 患者纳入早期组,Ⅲ级和Ⅳ级的 KOA 患者纳入进展期组,比较2 组患者的年龄、性别、体质量指数、病程及血清SFRP5、PGRN、GDF15 水平.采用Spearman 相关分析法分析血清SFRP5、PGRN、GDF15 水平与K-L 分级的相关性;采用二元 Logistic 回归模型分析血清SFRP5、PGRN、GDF15 水平与KOA 进展的关系.采用受试者工作特征(receiver operating characteristic,ROC)曲线分析血清 SFRP5、PGRN、GDF15 水平对 KOA 进展的预测价值.结果:KOA 组受试者血清 SFRP5 水平低于健康对照组(t=6.676,P=0.000),血清 PGRN、GDF15 水平均高于健康对照组(t=6.692,P=0.000;t=7.751,P=0.000).纳入研究的123 例 KOA 患者中,早期组31 例、进展期组92 例.2 组患者性别、年龄的组间差异均无统计学意义(χ2=0.004,P=0.947;t=1.874,P=0.063),体质量指数、病程的组间差异均有统计学意义(t=4.605,P=0.000;Z=3.452,P=0.000),且进展期组患者血清 SFRP5 水平低于早期组(t=4.601,P=0.000),血清 PGRN、GDF15 水平均高于早期组(t=4.926,P=0.000;t=5.135,P=0.000).相关性分析结果显示,血清 SFRP5 水平与 K-L 分级呈负相关(rs=-0.622,P=0.000),血清 PGRN、GDF15 水平与 K-L 分级呈正相关(rs=0.645,P=0.000;rs=0.681,P=0.000).二元 Logistic 回归分析结果显示,血清 SFRP5 水平是 KOA 进展的保护因素[β=-0.427,OR=0.652,95%CI(0.517,0.822),P=0.000],血清 PGRN、GDF15 水平是 KOA 进展的危险因素[β=0.196,OR=1.216,95%CI(1.079,1.371),P=0.001;β=0.017,OR=1.017,95%CI(1.007,1.027),P=0.001].血清 SFRP5、PGRN、GDF15 水平单独及联合诊断 KOA 进展的 ROC 曲线下面积分别为 0.786、0.764、0.803、0.913,三者联合预测的 ROC 曲线下面积大于三者单独预测(Z联合-SFRP5=3.987,P=0.000;Z联合-PGRN=4.555,P=0.000;Z联合-GDF15=3.764,P=0.000).结论:血清 SFRP5 水平是 KOA 进展的保护因素,血清 PGRN、GDF15 水平是 KOA 进展的危险因素;血清SFRP5、PGRN、GDF15 水平均能较好地预测 KOA 进展,且三者联合具有更佳的预测效能.
Objective:To investigate the predictive value of serum levels of secreted frizzled-related protein 5(SFRP5),progranulin(PGRN),and growth differentiation factor 15(GDF15)for the progression of knee osteoarthritis(KOA).Methods:A total of 123 patients with KOA admitted from March 2022 to March 2025 and 120 healthy volunteers recruited during the same period were selected.Clinical da-ta including gender,age,Kellgren-Lawrence(K-L)grade,body mass index(BMI),and disease course were collected for KOA patients,while clinical data including gender and age were collected for healthy volunteers.Venous blood was drawn from subjects in the early morning fasting state,and serum levels of SFRP5,PGRN,and GDF15 were detected by ELISA.The KOA patients were included in the KOA group,and the healthy volunteers were included in the healthy control group to compare serum levels of SFRP5,PGRN,and GDF15 between the two groups.The KOA patients with K-L gradesⅠandⅡwere included in the early stage group,while those with gradesⅢandⅣwere included in the progressive stage group;and the age,gender,BMI,disease course,and serum levels of SFRP5,PGRN,and GDF15 were compared be-tween the two groups.Spearman correlation analysis was used to analyze the correlation between serum levels of SFRP5,PGRN,GDF15,and K-L grades;dibasic logistic regression model was used to analyze the relationship between serum levels of SFRP5,PGRN,GDF15,and KOA progression.Receiver operating characteristic(ROC)curve was used to analyze the predictive value of serum SFRP5,PGRN,and GDF15 levels for KOA progression.Results:The serum SFRP5 levels in the KOA group were lower than those in the healthy control group(t=6.676,P=0.000),while the serum PGRN and GDF15 levels were higher than those in the healthy control group(t=6.692,P=0.000;t=7.751,P=0.000).Among the 123 patients with KOA enrolled in the study,there were 31 cases in the early stage group and 92 cases in the progressive stage group.There were no statistically significant differences in gender and age between the two groups(χ2=0.004,P=0.947;t=1.874,P=0.063),while there were statistically significant differences in BMI and disease course between the two groups(t=4.605,P=0.000;Z=3.452,P=0.000).Moreover,serum SFRP5 levels in the progressive stage group were lower than those in the early stage group(t=4.601,P=0.000),and serum PGRN and GDF15 levels were higher than those in the early stage group(t=4.926,P=0.000;t=5.135,P=0.000).Correlation analysis results showed that serum SFRP5 level was negatively correlated with K-L grade(rs=-0.622,P=0.000),while serum PGRN and GDF15 levels were positively correlated with K-L grade(rs=0.645,P=0.000;rs=0.681,P=0.000).Dibasic logistic regression analysis results showed that serum SFRP5 level was a protective factor for KOA progression(β=-0.427,OR=0.652,95%CI(0.517,0.822),P=0.000),while serum PGRN and GDF15 levels were risk factors for KOA progres-sion(β=0.196,OR=1.216,95%CI(1.079,1.371),P=0.001;β=0.017,OR=1.017,95%CI(1.007,1.027),P=0.001).The area under the ROC curve for serum SFRP5,PGRN,GDF15 levels alone and their combination in predicting KOA progression was 0.786,0.764,0.803,and 0.913,respectively.The area under the ROC curve for the combined prediction was greater than that of the three indivi-dual predictions(Zcombined-SFRP5=3.987,P=0.000;Zcombined-PGRN=4.555,P=0.000;Zcombined-GDF15=3.764,P=0.000).Conclusion:Serum SFRP5 level is a protective factor for KOA progression,while serum PGRN and GDF15 levels are risk factors for KOA progression.Serum SFRP5,PGRN,and GDF15 levels can all effectively predict KOA progression,and the combination of the three has better predictive efficacy.
郭鹏程;宋伟;郭北;徐艳红
张家口市第一医院,河北 张家口 075041张家口市第一医院,河北 张家口 075041张家口市第一医院,河北 张家口 075041张家口市第一医院,河北 张家口 075041
骨关节炎,膝疾病恶化分泌型卷曲相关蛋白颗粒蛋白前体生长分化因子15Logistic模型因素分析,统计学ROC曲线
osteoarthritis,kneedisease progressionsecreted frizzled-related proteinsprogranulinsgrowth differentiation factor 15logistic modelsfactor analysis,statisticalROC curve
《中医正骨》 2026 (5)
29-34,6
评论